Morozov Nicole, Fell Rafael, Mahmood Muhammad
Department of Internal Medicine, The Jewish Hospital (Bon Secours Mercy Health), Cincinnati, OH 45236, USA.
JCEM Case Rep. 2025 Apr 18;3(6):luaf072. doi: 10.1210/jcemcr/luaf072. eCollection 2025 Jun.
Maffucci syndrome (MS) is a congenital disorder caused by a gain-of-function variant in isocitrate dehydrogenase-1 () or isocitrate dehydrogenase-2 () genes on chromosomes 2 and 15, respectively. Common manifestations include the development of multiple enchondromas, chondrosarcomas, and intracranial tumors such as pituitary adenomas. Endocrinological conditions are less frequently associated with MS. We present a patient with MS with complete anterior pituitary insufficiency with central hypothyroidism, adrenal insufficiency, and hypogonadotropic hypogonadism, which may be related to the mass effect of her intracranial enchondromas. With hormonal treatments including thyroid hormone replacement, hydrocortisone, and cabergoline, the patient's symptoms of fatigue and cold intolerance improved. We highlight the importance of endocrinological evaluation in patients with neurological tumors related to MS.
马富西综合征(MS)是一种先天性疾病,分别由2号和15号染色体上的异柠檬酸脱氢酶-1(IDH1)或异柠檬酸脱氢酶-2(IDH2)基因的功能获得性变异引起。常见表现包括多发性内生软骨瘤、软骨肉瘤以及垂体腺瘤等颅内肿瘤的发生。内分泌疾病与MS的关联较少。我们报告了一名患有MS的患者,其存在完全性垂体前叶功能减退,伴有中枢性甲状腺功能减退、肾上腺功能不全和低促性腺激素性性腺功能减退,这可能与其颅内内生软骨瘤的占位效应有关。通过甲状腺激素替代、氢化可的松和卡麦角林等激素治疗,患者的疲劳和畏寒症状得到改善。我们强调了对与MS相关的神经肿瘤患者进行内分泌评估的重要性。